Intrexon Corporation, a Germantown, MD-based next generation synthetic biology company, closed a $150m Series F financing.
Backers included Randal J. Kirk, Chairman and CEO of Intrexon, and Third Security, LLC, as well as new undisclosed backers.
The company intends to use the funds to establish additional exclusive channel collaborations in its core sectors Healthcare, Food, Energy and Environment), continue to develop its technology platforms, and expand sales and marketing, and research and development efforts.
Intrexon Corporation designs and produces novel and enhanced biological products and processes across multiple industry sectors, including human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science.
31/05/2011: Intrexon Corporation Closes $100M Series E Financing